XML 32 R23.htm IDEA: XBRL DOCUMENT
v3.25.3

Note 14 - Earnings Per Share | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings Per Share [Abstract] |
Earnings Per Share | NOTE 14: EARNINGS PER SHARE Basic earnings per share are calculated using the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share calculations include any dilutive effect of potential common shares. In periods with a net loss available to common shareholders, diluted earnings per share are calculated using weighted-average basic shares for that period, as utilizing diluted shares would be anti-dilutive to loss per share. A reconciliation of the amounts used to calculate basic and diluted (loss) earnings per share for the three and nine months ended September 30, 2025 and 2024 follows:
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
(in millions) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Net earnings (loss) |  | $ | 13 |  |  | $ | 18 |  |  | $ | (20 | ) |  | $ | 76 |
Less: Series B Preferred stock cash and accrued dividends |  |  | (1 | ) |  |  | (1 | ) |  |  | (3 | ) |  |  | (3 | )
Less: Series C Preferred stock in-kind dividends |  |  | — |  |  |  | (2 | ) |  |  | (3 | ) |  |  | (5 | )
Less: Series C Preferred stock exchange to common stock deemed dividend |  |  | (19 | ) |  |  | — |  |  |  | (19 | ) |  |  | — |
Less: Preferred stock deemed dividends |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | (1 | )
Less: Earnings attributable to Series C Preferred shareholders |  |  | — |  |  |  | (2 | ) |  |  | — |  |  |  | (9 | )
Net (loss) earnings available to common shareholders - basic |  | $ | (7 | ) |  | $ | 13 |  |  | $ | (46 | ) |  | $ | 58 |
Effect of dilutive securities: |  |  |  |  |  |  |  |  |  |  |  |
Add back: Series B preferred stock cash, accrued and deemed dividends |  | $ | — |  |  | $ | 1 |  |  | $ | — |  |  | $ | 4 |
Net (loss) earnings available to common shareholders - diluted |  | $ | (7 | ) |  | $ | 14 |  |  | $ | (46 | ) |  | $ | 62 |
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
(in millions of shares) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Weighted averages shares - basic |  |  | 89.8 |  |  |  | 80.3 |  |  |  | 83.8 |  |  |  | 80.0 |
Effect of dilutive securities |  |  |  |  |  |  |  |  |  |  |  |
Unvested restricted stock units |  |  | — |  |  |  | 1.7 |  |  |  | — |  |  |  | 1.6 |
Employee stock options |  |  | — |  |  |  | 1.2 |  |  |  | — |  |  |  | 1.0 |
Series B Preferred Stock |  |  | — |  |  |  | 9.5 |  |  |  | — |  |  |  | 9.5 |
Weighted average shares — diluted |  |  | 89.8 |  |  |  | 92.7 |  |  |  | 83.8 |  |  |  | 92.1 |
As a result of the net loss available to common shareholders for the three and nine months ended September 30, 2025, Kodak calculated diluted earnings per share using weighted-average basic shares outstanding. If Kodak had reported earnings available to common shareholders for the three months ended September 30, 2025, the calculation of diluted earnings per share would have included the assumed vesting of 1.5 million unvested restricted stock units and the assumed exercise of 1.7 million stock options. For the nine months ended September 30, 2025, the calculation of diluted earnings per share would have included the assumed vesting of 1.6 million unvested restricted stock units and the assumed exercise of 1.7 million stock options. The computation of diluted earnings per share for the three and nine months ended September 30, 2025 excluded the impact of (1) the assumed conversion of 1.0 million shares of Series B Preferred Stock and (2) the assumed exercise of 1.7 million outstanding employee stock options because the effects would have been anti-dilutive. The computation of diluted earnings per share for the three and nine months ended September 30, 2024 excluded the impact of (1) the assumed conversion of 1.2 million shares of Series C Preferred Stock and (2) the assumed exercise of 2.6 million outstanding employee stock options because the effects would have been anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration